Literature DB >> 19720816

MDR-TB and XDR-TB: drug resistance and treatment outcomes.

G B Migliori, G Sotgiu, M D'Arcy Richardson, R Centis, A Facchini, G Guenther, A Spanevello, C Lange.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19720816     DOI： 10.1183/09031936.00059409

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  5 in total

Review 1.  Surgical treatment of drug-resistant tuberculosis.

Authors:  Russell R Kempker; Sergo Vashakidze; Nelly Solomonia; Nino Dzidzikashvili; Henry M Blumberg
Journal:  Lancet Infect Dis       Date:  2012-02       Impact factor: 25.071

2.  Computational design of MmpL3 inhibitors for tuberculosis therapy.

Authors:  R Chaitra; Rohit Gandhi; N Jayanna; Sachin Satyanath; Parasuraman Pavadai; Manikanta Murahari
Journal:  Mol Divers       Date:  2022-04-28       Impact factor: 2.943

3.  Survival of civilian and prisoner drug-sensitive, multi- and extensive drug- resistant tuberculosis cohorts prospectively followed in Russia.

Authors:  Yanina Balabanova; Vladyslav Nikolayevskyy; Olga Ignatyeva; Irina Kontsevaya; Clare M Rutterford; Anastasiya Shakhmistova; Nadezhda Malomanova; Yulia Chinkova; Svetlana Mironova; Ivan Fedorin; Francis A Drobniewski
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

4.  TBNET - Collaborative research on tuberculosis in Europe.

Authors:  C Giehl; C Lange; R Duarte; G Bothamley; C Gerlach; D M Cirillo; D Wagner; B Kampmann; D Goletti; T Juers; M Sester
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-12-11

5.  Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-centre study.

Authors:  F Bahraminia; M Zangiabadian; M J Nasiri; M Fattahi; M Goudarzi; R Ranjbar; A A Imani Fooladi
Journal:  New Microbes New Infect       Date:  2021-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.